Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis
Open Access
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trialAnnals of the Rheumatic Diseases, 2013
- Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblastsBone, 2011
- Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritisClimacteric, 2010
- Superoxide dismutase downregulation in osteoarthritis progression and end-stage diseaseAnnals of the Rheumatic Diseases, 2010
- Melatonin treatment normalizes plasma pro‐inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophyJournal of Pineal Research, 2010
- Osteoblasts play key roles in the mechanisms of action of strontium ranelateBritish Journal of Pharmacology, 2009
- Tratamento medicamentoso da osteoartrose do joelhoRevista Brasileira de Ortopedia, 2009
- Sirtinol attenuates hepatic injury and pro‐inflammatory cytokine production following trauma‐hemorrhage in male Sprague–Dawley ratsActa Anaesthesiologica Scandinavica, 2008
- Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitroBone, 2008
- Cardiovascular diseases: protective effects of melatoninJournal of Pineal Research, 2007